CHICAGO — An electronic frailty index may help to predict risk for poor outcomes, including mortality, in patients undergoing chemotherapy.“Chemotherapy treatment in older people often poses a difficult dilemma for clinicians,” Agnieszka Michael, PhD, MRCP, associate professor in oncology, consultant medical oncologist and medical director of Surrey Clinical Trials Unit at